Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 25 to 36 of 448 entries
Sorted by: Best Match Show Resources per page
Combining Cell-Free Protein Synthesis and NMR Into a Tool to Study Capsid Assembly Modulation.

Frontiers in molecular biosciences

Wang S, Fogeron ML, Schledorn M, Dujardin M, Penzel S, Burdette D, Berke JM, Nassal M, Lecoq L, Meier BH, Böckmann A.
PMID: 31440516
Front Mol Biosci. 2019 Aug 08;6:67. doi: 10.3389/fmolb.2019.00067. eCollection 2019.

Modulation of capsid assembly by small molecules has become a central concept in the fight against viral infection. Proper capsid assembly is crucial to form the high molecular weight structures that protect the viral genome and that, often in...

Cite
Wang S, Fogeron ML, Schledorn M, et al. Combining Cell-Free Protein Synthesis and NMR Into a Tool to Study Capsid Assembly Modulation. Front Mol Biosci. 2019;6:67doi: 10.3389/fmolb.2019.00067.
Wang, S., Fogeron, M. L., Schledorn, M., Dujardin, M., Penzel, S., Burdette, D., Berke, J. M., Nassal, M., Lecoq, L., Meier, B. H., & Böckmann, A. (2019). Combining Cell-Free Protein Synthesis and NMR Into a Tool to Study Capsid Assembly Modulation. Frontiers in molecular biosciences, 667. https://doi.org/10.3389/fmolb.2019.00067
Wang, Shishan, et al. "Combining Cell-Free Protein Synthesis and NMR Into a Tool to Study Capsid Assembly Modulation." Frontiers in molecular biosciences vol. 6 (2019): 67. doi: https://doi.org/10.3389/fmolb.2019.00067
Wang S, Fogeron ML, Schledorn M, Dujardin M, Penzel S, Burdette D, Berke JM, Nassal M, Lecoq L, Meier BH, Böckmann A. Combining Cell-Free Protein Synthesis and NMR Into a Tool to Study Capsid Assembly Modulation. Front Mol Biosci. 2019 Aug 08;6:67. doi: 10.3389/fmolb.2019.00067. eCollection 2019. PMID: 31440516; PMCID: PMC6694763.
Copy Download .nbib Format: NLM
Safety of whey basic protein isolate for extended uses in foods for special medical purposes and food supplements for infants pursuant to Regulation (EU) 2015/2283.

EFSA journal. European Food Safety Authority

, Turck D, Castenmiller J, de Henauw S, Hirsch-Ernst KI, Kearney J, Maciuk A, Mangelsdorf I, McArdle HJ, Naska A, Pelaez C, Pentieva K, Siani A, Thies F, Tsabouri S, Vinceti M, Cubadda F, Engel KH, Frenzel T, Heinonen M, Marchelli R, Neuhäuser-Berthold M, Pöting A, Poulsen M, Sanz Y, Schlatter JR, van Loveren H, Amundsen M, Knutsen HK.
PMID: 32626285
EFSA J. 2019 Apr 09;17(4):e05659. doi: 10.2903/j.efsa.2019.5659. eCollection 2019 Apr.

In 2018, the EFSA Panel on Nutrition, Novel Foods and Food Allergens (NDA) concluded that whey basic protein isolate obtained by ion exchange chromatography from skimmed cow's milk is safe for human consumption under the proposed conditions of use...

Cite
, Turck D, Castenmiller J, et al. Safety of whey basic protein isolate for extended uses in foods for special medical purposes and food supplements for infants pursuant to Regulation (EU) 2015/2283. EFSA J. 2019;17(4):e05659doi: 10.2903/j.efsa.2019.5659.
, Turck, D., Castenmiller, J., de Henauw, S., Hirsch-Ernst, K. I., Kearney, J., Maciuk, A., Mangelsdorf, I., McArdle, H. J., Naska, A., Pelaez, C., Pentieva, K., Siani, A., Thies, F., Tsabouri, S., Vinceti, M., Cubadda, F., Engel, K. H., Frenzel, T., Heinonen, M., Marchelli, R., Neuhäuser-Berthold, M., Pöting, A., Poulsen, M., Sanz, Y., Schlatter, J. R., van Loveren, H., Amundsen, M., & Knutsen, H. K. (2019). Safety of whey basic protein isolate for extended uses in foods for special medical purposes and food supplements for infants pursuant to Regulation (EU) 2015/2283. EFSA journal. European Food Safety Authority, 17(4), e05659. https://doi.org/10.2903/j.efsa.2019.5659
, et al. "Safety of whey basic protein isolate for extended uses in foods for special medical purposes and food supplements for infants pursuant to Regulation (EU) 2015/2283." EFSA journal. European Food Safety Authority vol. 17,4 (2019): e05659. doi: https://doi.org/10.2903/j.efsa.2019.5659
, Turck D, Castenmiller J, de Henauw S, Hirsch-Ernst KI, Kearney J, Maciuk A, Mangelsdorf I, McArdle HJ, Naska A, Pelaez C, Pentieva K, Siani A, Thies F, Tsabouri S, Vinceti M, Cubadda F, Engel KH, Frenzel T, Heinonen M, Marchelli R, Neuhäuser-Berthold M, Pöting A, Poulsen M, Sanz Y, Schlatter JR, van Loveren H, Amundsen M, Knutsen HK. Safety of whey basic protein isolate for extended uses in foods for special medical purposes and food supplements for infants pursuant to Regulation (EU) 2015/2283. EFSA J. 2019 Apr 09;17(4):e05659. doi: 10.2903/j.efsa.2019.5659. eCollection 2019 Apr. PMID: 32626285; PMCID: PMC7009248.
Copy Download .nbib Format: NLM
Ochratoxins A and B, Xanthomegnin, Viomellein and Vioxanthin Production by Isolates of Aspergillus ochraceus from Green Coffee Beans.

Journal of food protection

Stack ME, Mislivec PB, Denizel T, Gibson R, Pohland AE.
PMID: 30921851
J Food Prot. 1983 Nov;46(11):965-968. doi: 10.4315/0362-028X-46.11.965.

Isolates from Aspergillus ochraceus obtained from green coffee beans were cultured on rice and water. After 20 d of growth the cultures were extracted with chloroform and the extracts were analyzed by high performance liquid chromatography for ochratoxin A...

Cite
Stack ME, Mislivec PB, Denizel T, et al. Ochratoxins A and B, Xanthomegnin, Viomellein and Vioxanthin Production by Isolates of Aspergillus ochraceus from Green Coffee Beans. J Food Prot. 1983;46(11):965-968doi: 10.4315/0362-028X-46.11.965.
Stack, M. E., Mislivec, P. B., Denizel, T., Gibson, R., & Pohland, A. E. (1983). Ochratoxins A and B, Xanthomegnin, Viomellein and Vioxanthin Production by Isolates of Aspergillus ochraceus from Green Coffee Beans. Journal of food protection, 46(11), 965-968. https://doi.org/10.4315/0362-028X-46.11.965
Stack, Michael E, et al. "Ochratoxins A and B, Xanthomegnin, Viomellein and Vioxanthin Production by Isolates of Aspergillus ochraceus from Green Coffee Beans." Journal of food protection vol. 46,11 (1983): 965-968. doi: https://doi.org/10.4315/0362-028X-46.11.965
Stack ME, Mislivec PB, Denizel T, Gibson R, Pohland AE. Ochratoxins A and B, Xanthomegnin, Viomellein and Vioxanthin Production by Isolates of Aspergillus ochraceus from Green Coffee Beans. J Food Prot. 1983 Nov;46(11):965-968. doi: 10.4315/0362-028X-46.11.965. PMID: 30921851.
Copy Download .nbib Format: NLM
Safety of 2'-fucosyllactose/difucosyllactose mixture as a novel food pursuant to Regulation (EU) 2015/2283.

EFSA journal. European Food Safety Authority

, Turck D, Castenmiller J, De Henauw S, Hirsch-Ernst KI, Kearney J, Maciuk A, Mangelsdorf I, McArdle HJ, Naska A, Pelaez C, Pentieva K, Siani A, Thies F, Tsabouri S, Vinceti M, Cubadda F, Engel KH, Frenzel T, Heinonen M, Marchelli R, Neuhäuser-Berthold M, Pöting A, Poulsen M, Sanz Y, Schlatter JR, van Loveren H, Sun Q, Turla E, Knutsen HK.
PMID: 32626339
EFSA J. 2019 Jun 11;17(6):e05717. doi: 10.2903/j.efsa.2019.5717. eCollection 2019 Jun.

Following a request from the European Commission, the EFSA Panel on Nutrition, Novel Foods and Food Allergens (NDA) was asked to deliver an opinion on 2'-fucosyllactose/difucosyllactose (2'-FL/DFL) mixture as a novel food (NF) pursuant to Regulation (EU) 2015/2283. The...

Cite
, Turck D, Castenmiller J, et al. Safety of 2'-fucosyllactose/difucosyllactose mixture as a novel food pursuant to Regulation (EU) 2015/2283. EFSA J. 2019;17(6):e05717doi: 10.2903/j.efsa.2019.5717.
, Turck, D., Castenmiller, J., De Henauw, S., Hirsch-Ernst, K. I., Kearney, J., Maciuk, A., Mangelsdorf, I., McArdle, H. J., Naska, A., Pelaez, C., Pentieva, K., Siani, A., Thies, F., Tsabouri, S., Vinceti, M., Cubadda, F., Engel, K. H., Frenzel, T., Heinonen, M., Marchelli, R., Neuhäuser-Berthold, M., Pöting, A., Poulsen, M., Sanz, Y., Schlatter, J. R., van Loveren, H., Sun, Q., Turla, E., & Knutsen, H. K. (2019). Safety of 2'-fucosyllactose/difucosyllactose mixture as a novel food pursuant to Regulation (EU) 2015/2283. EFSA journal. European Food Safety Authority, 17(6), e05717. https://doi.org/10.2903/j.efsa.2019.5717
, et al. "Safety of 2'-fucosyllactose/difucosyllactose mixture as a novel food pursuant to Regulation (EU) 2015/2283." EFSA journal. European Food Safety Authority vol. 17,6 (2019): e05717. doi: https://doi.org/10.2903/j.efsa.2019.5717
, Turck D, Castenmiller J, De Henauw S, Hirsch-Ernst KI, Kearney J, Maciuk A, Mangelsdorf I, McArdle HJ, Naska A, Pelaez C, Pentieva K, Siani A, Thies F, Tsabouri S, Vinceti M, Cubadda F, Engel KH, Frenzel T, Heinonen M, Marchelli R, Neuhäuser-Berthold M, Pöting A, Poulsen M, Sanz Y, Schlatter JR, van Loveren H, Sun Q, Turla E, Knutsen HK. Safety of 2'-fucosyllactose/difucosyllactose mixture as a novel food pursuant to Regulation (EU) 2015/2283. EFSA J. 2019 Jun 11;17(6):e05717. doi: 10.2903/j.efsa.2019.5717. eCollection 2019 Jun. PMID: 32626339; PMCID: PMC7009083.
Copy Download .nbib Format: NLM
The Rise of (Chiral) 3D Mechanical Metamaterials.

Materials (Basel, Switzerland)

Reinbold J, Frenzel T, Münchinger A, Wegener M.
PMID: 31661805
Materials (Basel). 2019 Oct 28;12(21). doi: 10.3390/ma12213527.

On the occasion of this special issue, we start by briefly outlining some of the history and future perspectives of the field of 3D metamaterials in general and 3D mechanical metamaterials in particular. Next, in the spirit of a...

Cite
Reinbold J, Frenzel T, Münchinger A, et al. The Rise of (Chiral) 3D Mechanical Metamaterials. Materials (Basel). 2019;12(21)doi: 10.3390/ma12213527.
Reinbold, J., Frenzel, T., Münchinger, A., & Wegener, M. (2019). The Rise of (Chiral) 3D Mechanical Metamaterials. Materials (Basel, Switzerland), 12(21), . https://doi.org/10.3390/ma12213527
Reinbold, Janet, et al. "The Rise of (Chiral) 3D Mechanical Metamaterials." Materials (Basel, Switzerland) vol. 12,21 (2019). doi: https://doi.org/10.3390/ma12213527
Reinbold J, Frenzel T, Münchinger A, Wegener M. The Rise of (Chiral) 3D Mechanical Metamaterials. Materials (Basel). 2019 Oct 28;12(21). doi: 10.3390/ma12213527. PMID: 31661805; PMCID: PMC6862497.
Copy Download .nbib Format: NLM
Isolated mechanical aortic valve replacement in rheumatic patients in a low- to middle-income country.

The Journal of thoracic and cardiovascular surgery

Scherman J, Manganyi R, Human P, Pennel T, Brooks A, Brink J, Zilla P.
PMID: 30107929
J Thorac Cardiovasc Surg. 2019 Mar;157(3):886-893. doi: 10.1016/j.jtcvs.2018.06.083. Epub 2018 Jul 20.

OBJECTIVE: Although the results of aortic valve replacement are well documented for industrialized countries, the outcome in patients with rheumatic aortic valve disease in low- to middle-income countries is less well explored. The aim of this study was to...

Cite
Scherman J, Manganyi R, Human P, et al. Isolated mechanical aortic valve replacement in rheumatic patients in a low- to middle-income country. J Thorac Cardiovasc Surg. 2018;157(3):886-893doi: 10.1016/j.jtcvs.2018.06.083.
Scherman, J., Manganyi, R., Human, P., Pennel, T., Brooks, A., Brink, J., & Zilla, P. (2019). Isolated mechanical aortic valve replacement in rheumatic patients in a low- to middle-income country. The Journal of thoracic and cardiovascular surgery, 157(3), 886-893. https://doi.org/10.1016/j.jtcvs.2018.06.083
Scherman, Jacques, et al. "Isolated mechanical aortic valve replacement in rheumatic patients in a low- to middle-income country." The Journal of thoracic and cardiovascular surgery vol. 157,3 (2019): 886-893. doi: https://doi.org/10.1016/j.jtcvs.2018.06.083
Scherman J, Manganyi R, Human P, Pennel T, Brooks A, Brink J, Zilla P. Isolated mechanical aortic valve replacement in rheumatic patients in a low- to middle-income country. J Thorac Cardiovasc Surg. 2019 Mar;157(3):886-893. doi: 10.1016/j.jtcvs.2018.06.083. Epub 2018 Jul 20. PMID: 30107929.
Copy Download .nbib Format: NLM
Superconducting energy gap in MBa.

Physical review. B, Condensed matter

Barahona M, Bauer M, Cabanas MV, Cardona M, García E, Genzel L, König W, Wittlin A.
PMID: 9943643
Phys Rev B Condens Matter. 1988 Jan 01;37(1):652-655. doi: 10.1103/physrevb.37.652.

No abstract available.

Cite
Barahona M, Bauer M, Cabanas MV, et al. Superconducting energy gap in MBa. Phys Rev B Condens Matter. 1988;37(1):652-655doi: 10.1103/physrevb.37.652.
Barahona, M., Bauer, M., Cabanas, M. V., Cardona, M., García, E., Genzel, L., König, W., & Wittlin, A. (1988). Superconducting energy gap in MBa. Physical review. B, Condensed matter, 37(1), 652-655. https://doi.org/10.1103/physrevb.37.652
Barahona, et al. "Superconducting energy gap in MBa." Physical review. B, Condensed matter vol. 37,1 (1988): 652-655. doi: https://doi.org/10.1103/physrevb.37.652
Barahona M, Bauer M, Cabanas MV, Cardona M, García E, Genzel L, König W, Wittlin A. Superconducting energy gap in MBa. Phys Rev B Condens Matter. 1988 Jan 01;37(1):652-655. doi: 10.1103/physrevb.37.652. PMID: 9943643.
Copy Download .nbib Format: NLM
Relationships between childhood trauma and perceived stress in the general population: a network perspective.

Psychological medicine

Betz LT, Penzel N, Rosen M, Kambeitz J.
PMID: 32404227
Psychol Med. 2021 Nov;51(15):2696-2706. doi: 10.1017/S003329172000135X. Epub 2020 May 14.

BACKGROUND: Experiences of childhood trauma (CT) are associated with increased psychological vulnerability. Past research suggests that CT might alter stress processing with a subsequent negative impact on mental health. However, it is currently unclear how different domains of CT...

Cite
Betz LT, Penzel N, Rosen M, et al. Relationships between childhood trauma and perceived stress in the general population: a network perspective. Psychol Med. 2020;51(15):2696-2706doi: 10.1017/S003329172000135X.
Betz, L. T., Penzel, N., Rosen, M., & Kambeitz, J. (2021). Relationships between childhood trauma and perceived stress in the general population: a network perspective. Psychological medicine, 51(15), 2696-2706. https://doi.org/10.1017/S003329172000135X
Betz, Linda T, et al. "Relationships between childhood trauma and perceived stress in the general population: a network perspective." Psychological medicine vol. 51,15 (2021): 2696-2706. doi: https://doi.org/10.1017/S003329172000135X
Betz LT, Penzel N, Rosen M, Kambeitz J. Relationships between childhood trauma and perceived stress in the general population: a network perspective. Psychol Med. 2021 Nov;51(15):2696-2706. doi: 10.1017/S003329172000135X. Epub 2020 May 14. PMID: 32404227.
Copy Download .nbib Format: NLM
Safety of 3-FL (3-Fucosyllactose) as a novel food pursuant to Regulation (EU) 2015/2283.

EFSA journal. European Food Safety Authority

, Turck D, Castenmiller J, De Henauw S, Hirsch-Ernst KI, Kearney J, Maciuk A, Mangelsdorf I, McArdle HJ, Naska A, Pelaez C, Pentieva K, Siani A, Thies F, Tsabouri S, Vinceti M, Cubadda F, Frenzel T, Heinonen M, Marchelli R, Neuhäuser-Berthold M, Poulsen M, Maradona MP, Schlatter JR, van Loveren H, Colombo P, Knutsen HK.
PMID: 34221147
EFSA J. 2021 Jun 30;19(6):e06662. doi: 10.2903/j.efsa.2021.6662. eCollection 2021 Jun.

Following a request from the European Commission, the EFSA Panel on Nutrition, Novel Foods and Food Allergens (NDA) was asked to deliver an opinion on 3-fucosyllactose (3-FL) as a novel food (NF) pursuant to Regulation (EU) 2015/2283. The NF...

Cite
, Turck D, Castenmiller J, et al. Safety of 3-FL (3-Fucosyllactose) as a novel food pursuant to Regulation (EU) 2015/2283. EFSA J. 2021;19(6):e06662doi: 10.2903/j.efsa.2021.6662.
, Turck, D., Castenmiller, J., De Henauw, S., Hirsch-Ernst, K. I., Kearney, J., Maciuk, A., Mangelsdorf, I., McArdle, H. J., Naska, A., Pelaez, C., Pentieva, K., Siani, A., Thies, F., Tsabouri, S., Vinceti, M., Cubadda, F., Frenzel, T., Heinonen, M., Marchelli, R., Neuhäuser-Berthold, M., Poulsen, M., Maradona, M. P., Schlatter, J. R., van Loveren, H., Colombo, P., & Knutsen, H. K. (2021). Safety of 3-FL (3-Fucosyllactose) as a novel food pursuant to Regulation (EU) 2015/2283. EFSA journal. European Food Safety Authority, 19(6), e06662. https://doi.org/10.2903/j.efsa.2021.6662
, et al. "Safety of 3-FL (3-Fucosyllactose) as a novel food pursuant to Regulation (EU) 2015/2283." EFSA journal. European Food Safety Authority vol. 19,6 (2021): e06662. doi: https://doi.org/10.2903/j.efsa.2021.6662
, Turck D, Castenmiller J, De Henauw S, Hirsch-Ernst KI, Kearney J, Maciuk A, Mangelsdorf I, McArdle HJ, Naska A, Pelaez C, Pentieva K, Siani A, Thies F, Tsabouri S, Vinceti M, Cubadda F, Frenzel T, Heinonen M, Marchelli R, Neuhäuser-Berthold M, Poulsen M, Maradona MP, Schlatter JR, van Loveren H, Colombo P, Knutsen HK. Safety of 3-FL (3-Fucosyllactose) as a novel food pursuant to Regulation (EU) 2015/2283. EFSA J. 2021 Jun 30;19(6):e06662. doi: 10.2903/j.efsa.2021.6662. eCollection 2021 Jun. PMID: 34221147; PMCID: PMC8243255.
Copy Download .nbib Format: NLM
Experience.

World neurosurgery

Benzel E.
PMID: 34802682
World Neurosurg. 2021 Dec;156:xiii. doi: 10.1016/j.wneu.2021.09.096.

No abstract available.

Cite
Benzel E. Experience. World Neurosurg. 2021;156:xiiidoi: 10.1016/j.wneu.2021.09.096.
Benzel, E. (2021). Experience. World neurosurgery, 156xiii. https://doi.org/10.1016/j.wneu.2021.09.096
Benzel, Ed. "Experience." World neurosurgery vol. 156 (2021): xiii. doi: https://doi.org/10.1016/j.wneu.2021.09.096
Benzel E. Experience. World Neurosurg. 2021 Dec;156:xiii. doi: 10.1016/j.wneu.2021.09.096. PMID: 34802682.
Copy Download .nbib Format: NLM
Nocturnal respiratory rate predicts ICD benefit: A prospective, controlled, multicentre cohort study.

EClinicalMedicine

Dommasch M, Steger A, Barthel P, Huster KM, Müller A, Sinnecker D, Laugwitz KL, Penzel T, Lubinski A, Flevari P, Harden M, Friede T, Kääb S, Merkely B, Sticherling C, Willems R, Huikuri HV, Bauer A, Malik M, Zabel M, Schmidt G.
PMID: 33554086
EClinicalMedicine. 2020 Dec 21;31:100695. doi: 10.1016/j.eclinm.2020.100695. eCollection 2021 Jan.

BACKGROUND: Implantable cardioverter defibrillators (ICDs) prevent sudden cardiac death. ICD implantation decisions are currently based on reduced left ventricular ejection fraction (LVEF≤35%). However, in some patients, the non-arrhythmic death risk predominates thus diminishing ICD-therapy benefits. Based on previous observations,...

Cite
Dommasch M, Steger A, Barthel P, et al. Nocturnal respiratory rate predicts ICD benefit: A prospective, controlled, multicentre cohort study. EClinicalMedicine. 2020;31:100695doi: 10.1016/j.eclinm.2020.100695.
Dommasch, M., Steger, A., Barthel, P., Huster, K. M., Müller, A., Sinnecker, D., Laugwitz, K. L., Penzel, T., Lubinski, A., Flevari, P., Harden, M., Friede, T., Kääb, S., Merkely, B., Sticherling, C., Willems, R., Huikuri, H. V., Bauer, A., Malik, M., Zabel, M., Schmidt, G. (2021). Nocturnal respiratory rate predicts ICD benefit: A prospective, controlled, multicentre cohort study. EClinicalMedicine, 31100695. https://doi.org/10.1016/j.eclinm.2020.100695
Dommasch, Michael, et al. "Nocturnal respiratory rate predicts ICD benefit: A prospective, controlled, multicentre cohort study." EClinicalMedicine vol. 31 (2021): 100695. doi: https://doi.org/10.1016/j.eclinm.2020.100695
Dommasch M, Steger A, Barthel P, Huster KM, Müller A, Sinnecker D, Laugwitz KL, Penzel T, Lubinski A, Flevari P, Harden M, Friede T, Kääb S, Merkely B, Sticherling C, Willems R, Huikuri HV, Bauer A, Malik M, Zabel M, Schmidt G. Nocturnal respiratory rate predicts ICD benefit: A prospective, controlled, multicentre cohort study. EClinicalMedicine. 2020 Dec 21;31:100695. doi: 10.1016/j.eclinm.2020.100695. eCollection 2021 Jan. PMID: 33554086; PMCID: PMC7846675.
Copy Download .nbib Format: NLM
The Dutch Data Warehouse, a multicenter and full-admission electronic health records database for critically ill COVID-19 patients.

Critical care (London, England)

Fleuren LM, Dam TA, Tonutti M, de Bruin DP, Lalisang RCA, Gommers D, Cremer OL, Bosman RJ, Rigter S, Wils EJ, Frenzel T, Dongelmans DA, de Jong R, Peters M, Kamps MJA, Ramnarain D, Nowitzky R, Nooteboom FGCA, de Ruijter W, Urlings-Strop LC, Smit EGM, Mehagnoul-Schipper DJ, Dormans T, de Jager CPC, Hendriks SHA, Achterberg S, Oostdijk E, Reidinga AC, Festen-Spanjer B, Brunnekreef GB, Cornet AD, van den Tempel W, Boelens AD, Koetsier P, Lens J, Faber HJ, Karakus A, Entjes R, de Jong P, Rettig TCD, Arbous S, Vonk SJJ, Fornasa M, Machado T, Houwert T, Hovenkamp H, Noorduijn-Londono R, Quintarelli D, Scholtemeijer MG, de Beer AA, Cina G, Beudel M, Herter WE, Girbes ARJ, Hoogendoorn M, Thoral PJ, Elbers PWG.
PMID: 34425864
Crit Care. 2021 Aug 23;25(1):304. doi: 10.1186/s13054-021-03733-z.

BACKGROUND: The Coronavirus disease 2019 (COVID-19) pandemic has underlined the urgent need for reliable, multicenter, and full-admission intensive care data to advance our understanding of the course of the disease and investigate potential treatment strategies. In this study, we...

Cite
Fleuren LM, Dam TA, Tonutti M, et al. The Dutch Data Warehouse, a multicenter and full-admission electronic health records database for critically ill COVID-19 patients. Crit Care. 2021;25(1):304doi: 10.1186/s13054-021-03733-z.
Fleuren, L. M., Dam, T. A., Tonutti, M., de Bruin, D. P., Lalisang, R. C. A., Gommers, D., Cremer, O. L., Bosman, R. J., Rigter, S., Wils, E. J., Frenzel, T., Dongelmans, D. A., de Jong, R., Peters, M., Kamps, M. J. A., Ramnarain, D., Nowitzky, R., Nooteboom, F. G. C. A., de Ruijter, W., Urlings-Strop, L. C., Smit, E. G. M., Mehagnoul-Schipper, D. J., Dormans, T., de Jager, C. P. C., Hendriks, S. H. A., Achterberg, S., Oostdijk, E., Reidinga, A. C., Festen-Spanjer, B., Brunnekreef, G. B., Cornet, A. D., van den Tempel, W., Boelens, A. D., Koetsier, P., Lens, J., Faber, H. J., Karakus, A., Entjes, R., de Jong, P., Rettig, T. C. D., Arbous, S., Vonk, S. J. J., Fornasa, M., Machado, T., Houwert, T., Hovenkamp, H., Noorduijn-Londono, R., Quintarelli, D., Scholtemeijer, M. G., de Beer, A. A., Cina, G., Beudel, M., Herter, W. E., Girbes, A. R. J., Hoogendoorn, M., Thoral, P. J., & Elbers, P. W. G. (2021). The Dutch Data Warehouse, a multicenter and full-admission electronic health records database for critically ill COVID-19 patients. Critical care (London, England), 25(1), 304. https://doi.org/10.1186/s13054-021-03733-z
Fleuren, Lucas M, et al. "The Dutch Data Warehouse, a multicenter and full-admission electronic health records database for critically ill COVID-19 patients." Critical care (London, England) vol. 25,1 (2021): 304. doi: https://doi.org/10.1186/s13054-021-03733-z
Fleuren LM, Dam TA, Tonutti M, de Bruin DP, Lalisang RCA, Gommers D, Cremer OL, Bosman RJ, Rigter S, Wils EJ, Frenzel T, Dongelmans DA, de Jong R, Peters M, Kamps MJA, Ramnarain D, Nowitzky R, Nooteboom FGCA, de Ruijter W, Urlings-Strop LC, Smit EGM, Mehagnoul-Schipper DJ, Dormans T, de Jager CPC, Hendriks SHA, Achterberg S, Oostdijk E, Reidinga AC, Festen-Spanjer B, Brunnekreef GB, Cornet AD, van den Tempel W, Boelens AD, Koetsier P, Lens J, Faber HJ, Karakus A, Entjes R, de Jong P, Rettig TCD, Arbous S, Vonk SJJ, Fornasa M, Machado T, Houwert T, Hovenkamp H, Noorduijn-Londono R, Quintarelli D, Scholtemeijer MG, de Beer AA, Cina G, Beudel M, Herter WE, Girbes ARJ, Hoogendoorn M, Thoral PJ, Elbers PWG. The Dutch Data Warehouse, a multicenter and full-admission electronic health records database for critically ill COVID-19 patients. Crit Care. 2021 Aug 23;25(1):304. doi: 10.1186/s13054-021-03733-z. PMID: 34425864; PMCID: PMC8381710.
Copy Download .nbib Format: NLM
Showing 25 to 36 of 448 entries